416 related articles for article (PubMed ID: 25972356)
1. Deubiquitinases in cancer.
Wei R; Liu X; Yu W; Yang T; Cai W; Liu J; Huang X; Xu GT; Zhao S; Yang J; Liu S
Oncotarget; 2015 May; 6(15):12872-89. PubMed ID: 25972356
[TBL] [Abstract][Full Text] [Related]
2. Deubiquitinases and the new therapeutic opportunities offered to cancer.
Pfoh R; Lacdao IK; Saridakis V
Endocr Relat Cancer; 2015 Feb; 22(1):T35-54. PubMed ID: 25605410
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitinases (DUBs) and DUB inhibitors: a patent review.
Farshi P; Deshmukh RR; Nwankwo JO; Arkwright RT; Cvek B; Liu J; Dou QP
Expert Opin Ther Pat; 2015; 25(10):1191-1208. PubMed ID: 26077642
[TBL] [Abstract][Full Text] [Related]
4. Deubiquitinase inhibition as a cancer therapeutic strategy.
D'Arcy P; Wang X; Linder S
Pharmacol Ther; 2015 Mar; 147():32-54. PubMed ID: 25444757
[TBL] [Abstract][Full Text] [Related]
5. Emerging potential of therapeutic targeting of ubiquitin-specific proteases in the treatment of cancer.
Pal A; Young MA; Donato NJ
Cancer Res; 2014 Sep; 74(18):4955-66. PubMed ID: 25172841
[TBL] [Abstract][Full Text] [Related]
6. DUBs, the regulation of cell identity and disease.
Heideker J; Wertz IE
Biochem J; 2015 Jan; 465(1):1-26. PubMed ID: 25631680
[TBL] [Abstract][Full Text] [Related]
7. Deubiquitinating enzymes as novel anticancer targets.
Nicholson B; Marblestone JG; Butt TR; Mattern MR
Future Oncol; 2007 Apr; 3(2):191-9. PubMed ID: 17381419
[TBL] [Abstract][Full Text] [Related]
8. Activity-based probes for the ubiquitin conjugation-deconjugation machinery: new chemistries, new tools, and new insights.
Hewings DS; Flygare JA; Bogyo M; Wertz IE
FEBS J; 2017 May; 284(10):1555-1576. PubMed ID: 28196299
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-specific proteases as cancer drug targets.
Sippl W; Collura V; Colland F
Future Oncol; 2011 May; 7(5):619-32. PubMed ID: 21568678
[TBL] [Abstract][Full Text] [Related]
10. Deubiquitinases and cancer: A snapshot.
Singh N; Singh AB
Crit Rev Oncol Hematol; 2016 Jul; 103():22-6. PubMed ID: 27211605
[TBL] [Abstract][Full Text] [Related]
11. Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors.
Chen S; Liu Y; Zhou H
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925279
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the development of deubiquitinases inhibitors as antitumor agents.
Zheng LL; Wang LT; Pang YW; Sun LP; Shi L
Eur J Med Chem; 2024 Feb; 266():116161. PubMed ID: 38262120
[TBL] [Abstract][Full Text] [Related]
13. Measurement of deubiquitinating enzyme activity via a suicidal HA-Ub-VS probe.
Rivard C; Bazzaro M
Methods Mol Biol; 2015; 1249():193-200. PubMed ID: 25348307
[TBL] [Abstract][Full Text] [Related]
14. Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents.
Chen X; Yang Q; Xiao L; Tang D; Dou QP; Liu J
Cancer Metastasis Rev; 2017 Dec; 36(4):655-668. PubMed ID: 29039082
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of proteasome deubiquitinase activity: a strategy to overcome resistance to conventional proteasome inhibitors?
Selvaraju K; Mazurkiewicz M; Wang X; Gullbo J; Linder S; D'Arcy P
Drug Resist Updat; 2015; 21-22():20-9. PubMed ID: 26183292
[TBL] [Abstract][Full Text] [Related]
16. Toward understanding ubiquitin-modifying enzymes: from pharmacological targeting to proteomics.
Lill JR; Wertz IE
Trends Pharmacol Sci; 2014 Apr; 35(4):187-207. PubMed ID: 24717260
[TBL] [Abstract][Full Text] [Related]
17. Biological functions of hyaluronan and cytokine-inducible deubiquitinating enzymes.
Ramakrishna S; Suresh B; Baek KH
Biochim Biophys Acta; 2015 Jan; 1855(1):83-91. PubMed ID: 25481051
[TBL] [Abstract][Full Text] [Related]
18. The bad seed gardener: Deubiquitinases in the cancer stem-cell signaling network and therapeutic resistance.
Qiu GZ; Sun W; Jin MZ; Lin J; Lu PG; Jin WL
Pharmacol Ther; 2017 Apr; 172():127-138. PubMed ID: 27919796
[TBL] [Abstract][Full Text] [Related]
19. Catching a DUB in the act: novel ubiquitin-based active site directed probes.
Ekkebus R; Flierman D; Geurink PP; Ovaa H
Curr Opin Chem Biol; 2014 Dec; 23():63-70. PubMed ID: 25461387
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathways: translational potential of deubiquitinases as drug targets.
D'Arcy P; Linder S
Clin Cancer Res; 2014 Aug; 20(15):3908-14. PubMed ID: 25085788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
